Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1-3N0M0

被引:14
|
作者
Wu, Lei-Lei [1 ,2 ]
Zhong, Jiu-Di [3 ]
Zhu, Jia-Li [4 ]
Kang, Lu
Huang, Yang-Yu
Lin, Peng
Long, Hao
Zhang, Lan-Jun
Ma, Qi-Long [5 ,6 ]
Qiu, Li-Hong [6 ]
Ma, Guo-Wei [3 ,6 ]
机构
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Canc Ctr, State Key Lab Oncol South China, Guangzhou 510060, Peoples R China
[2] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Thorac Surg, Shanghai, Peoples R China
[3] Guangdong Esophageal Canc Inst, Guangzhou 510060, Peoples R China
[4] Tongji Univ, Sch Med, Shanghai, Peoples R China
[5] Jinling Hosp, Nanjing 210000, Peoples R China
[6] Sun Yat Sen Univ, Canc Ctr, Dept Thorac Surg, 651 Dongfengdong Rd, Guangzhou 510060, Peoples R China
关键词
Esophageal squamous cell carcinoma; Overall survival; Lymph node; SEER; CANCER; IMPACT;
D O I
10.1186/s12885-022-09207-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The postoperative survival effect of the number of examined lymph nodes on patients of R0-resected esophageal squamous cell carcinoma with pathological stage T1-3N0M0 is still unclear. Methods Patients diagnosed with pathological stage T1-3N0M0 esophageal squamous cell carcinoma from two cancer databases-our cancer center (N = 707), and Surveillance Epidemiology and End Results (N = 151). The primary clinical endpoint was overall survival. The X-tile software was used to determine the optimal cutoff value of the number of examined lymph nodes, and propensity score matching was conducted to reduce selection bias according to the results of X-tile software. The cohort of 151 patients from another database was used for validation. Results X-tile software provided an optimal cutoff value of 15 examined lymph nodes based on 707 patients, and 231 pairs of matched patients were included. In the unmatched cohort, Cox proportional hazard regression analysis revealed better overall survival in patients with more than 15 examined lymph nodes (adjusted hazard ratio, 0.566, 95% confidence interval, 0.445-0.720; p < 0.001) compared with patients with 15 or fewer examined lymph nodes. In the validation cohort, patients with more than 15 examined lymph nodes also had better overall survival (adjusted hazard ratio 0.665, p = 0.047). Conclusions The number of examined lymph nodes is a significant prognostic factor in esophageal squamous cell carcinoma patients with pathological stage T1-3N0M0, and more than 15 examined lymph nodes are associated with better overall survival. Although the difference is not significant, the survival curve of patients with examined lymph nodes > 30 is better than those with examined lymph nodes 15-30. We believe that the number of examined lymph nodes can provide prognostic guidance for those patients, and the more examined lymph nodes cause lesser occult lymph nodes metastasis and lead to a better prognosis. Therefore, surgeons and pathologists should try to examine as many lymph nodes as possible to evaluate the pathological stage precisely. However, we need more validation from other studies.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Effect of chemotherapy on survival in patients with stage T3-4N0M0 nasopharyngeal carcinoma
    Pan, Xin-Bin
    Qu, Song
    Li, Ling
    Chen, Long
    Liang, Shi-Xiong
    Zhu, Xiao-Dong
    CLINICAL OTOLARYNGOLOGY, 2021, 46 (04) : 802 - 808
  • [32] Patterns of Lymph Node Recurrence after Radical Surgery Impacting on Survival of Patients with pT1-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma
    Chen, Xiao-li
    Chen, Tian-wu
    Fang, Zhi-jia
    Zhang, Xiao-ming
    Li, Zhen-lin
    Li, Hang
    Tang, Hong-jie
    Zhou, Li
    Wang, Dan
    Zhang, Zishu
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 (02) : 217 - 223
  • [33] Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx Reply
    Witek, Matthew E.
    Hartig, Gregory K.
    Harari, Paul M.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2018, 144 (06) : 543 - 543
  • [34] Impact of the examined number of lymph nodes at N1 station on the prognosis of patients with pT1-3N0M0 non-small cell lung cancer
    王高祥
    ChinaMedicalAbstracts(InternalMedicine), 2022, 39 (02) : 102 - 103
  • [35] Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy
    Zhou, Jian
    Heng, Yu
    Yang, Yue
    Zhu, Xiaoke
    Zhou, Liang
    Gong, Hongli
    Xu, Chengzhi
    Tao, Lei
    ONCOLOGY LETTERS, 2022, 24 (06)
  • [36] Lymphangiogenesis in regional lymph nodes predicts nodal recurrence in pathological N0 squamous cell carcinoma of the tongue
    Hirota, Kyoko
    Wakisaka, Naohiro
    Sawada-Kitamura, Seiko
    Kondo, Satoru
    Endo, Kazuhira
    Tsuji, Akira
    Murono, Shigeyuki
    Yoshizaki, Tomokazu
    HISTOPATHOLOGY, 2012, 61 (06) : 1065 - 1071
  • [37] Reply to: Insufficient number of examined lymph nodes may offset the survival benefit from neoadjuvant therapy in esophageal squamous cell carcinoma
    Franko, Jan
    McAvoy, Sarah
    SURGERY, 2019, 165 (03) : 664 - 665
  • [38] Risk factors for postoperative recurrence of pT2-3N0M0 esophageal squamous cell carcinoma and patterns of its recurrence
    Niu, Li
    Hu, Bo
    Zhang, Li
    Kang, Mei
    BIOSCIENCE TRENDS, 2023, 17 (06) : 475 - 483
  • [39] Patterns of failure and long-term outcome of postoperative radiotherapy on the survival of patients with pathological T3N0M0 esophageal cancer
    Song, Chunyang
    Zhu, Shuchai
    Xu, Jinrui
    Su, Jingwei
    Zhang, Xueyuan
    Deng, Wenzhao
    Zhao, Xiaohan
    Shen, Wenbin
    FRONTIERS IN SURGERY, 2022, 9
  • [40] The minimum number of examined lymph nodes for accurate nodal staging and optimal survival of stage T1-2 esophageal squamous cell carcinoma: A retrospective multicenter cohort with SEER database validation
    Tian, Dong
    Li, Hao-Xuan
    Yang, Yu-Shang
    Yan, Hao-Ji
    Jiang, Kai-Yuan
    Zheng, Yin-Bin
    Zong, Zheng-Dong
    Zhang, Han-Lu
    Guo, Xiao-Guang
    Wen, Hong-Ying
    Chen, Long-Qi
    INTERNATIONAL JOURNAL OF SURGERY, 2022, 104